Feb 21, 2024 / 10:00PM GMT
Operator
Hello, and welcome to the Arcus Biosciences' full year/Q4 2023 earnings call. My name is Elliott, and I'll be coordinating your call today. (Operator Instructions)
I'd now like to hand over to Pia Eaves, Vice President of Investor Relations. The floor is yours.
Pia Eaves - Arcus Biosciences Inc - Vice President, Investor Relations
Hello, everyone, and thank you for joining us on today's conference call to discuss Arcus's fourth-quarter 2023 financial results and pipeline update. I'd like to remind you that on this call, management will make forward-looking statements, including statements about our cash runway and our expected clinical development, milestones, and timelines.
All statements other than historical facts reflect the current beliefs and expectations of management and involve risks and uncertainties that may cause our actual results to differ from those expressed. Those risks and uncertainties are described in our annual report on Form 10-K, which has been filed with the SEC. We strongly encourage you to review our filings.
Q4 2023 Arcus Biosciences Inc Earnings Call Transcript
Feb 28, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers